Positive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancer

Disease Markers

Volumn 35, Issue 3, 2013, Pages 163-172

  Yang, Zhu Lin ^a   Yang, Leping ^a   Zou, Qiong ^b   Yuan, Yuan ^b   Li, Jinghe ^c   Liang, Lufeng ^d   Zeng, Guixiang ^e   Chen, Senlin ^f  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^c Central South University   (China)

^d People's Hospital of Hunan   (China)

^e Loudi Central Hospital   (China)

^f HUNAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A3; GLUTATHIONE PEROXIDASE 3; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; GALLBLADDER CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ALDEHYDE OXIDOREDUCTASES; CARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884267565     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/187043     Document Type: Article

References (35)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M. J., Cancer statistics, 2008. CA Cancer Journal for Clinicians 2008 58 2 71 96 2-s2.0-41349099104 10.3322/CA.2007.0010 (Pubitemid 351521864)
2. Jayaraman S., Jarnagin W. R., Management of gallbladder cancer. Gastroenterology Clinics of North America 2010 39 2 331 342 2-s2.0-77952804734 10.1016/j.gtc.2010.02.006
3. Hawkins W. G., DeMatteo R. P., Jarnagin W. R., Ben-Porat L., Blumgart L. H., Fong Y., Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Annals of Surgical Oncology 2004 11 3 310 315 2-s2.0-2442714264 10.1245/ASO.2004.03.011 (Pubitemid 40486772)
4. Reid K. M., La Medina A. R., Donohue J. H., Diagnosis and surgical management of gallbladder cancer: a review. Journal of Gastrointestinal Surgery 2007 11 5 671 681 2-s2.0-34247560814 10.1007/s11605-006-0075-x
5. De Aretxabala X., Roa I., Burgos L., Losada H., Roa J. C., Mora J., Hepp J., Leon J., Maluenda F., Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer. Journal of Gastrointestinal Surgery 2006 10 2 186 192 2-s2.0-31944447885 10.1016/j.gassur.2005.11.003 (Pubitemid 43187179)
6. Ootani T., Shirai Y., Tsukada K., Muto T., Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer 1992 69 2647 2652
7. Roa J. C., Tapia O., Cakir A., Basturk O., Dursun N., Akdemir D., Saka B., Losada H., Bagci P., Adsay N. V., Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas. Modern Pathology 2011 24 8 1069 1078 2-s2.0-79961029831 10.1038/modpathol.2011.68
8. Park S. B., Kim Y. H., Rho H. L., Chae G. B., Hong S. K., Primary carcinosarcoma of the gallbladder. Journal of the Korean Surgical Society 2012 82 1 54 58 2-s2.0-84856648583 10.4174/jkss.2012.82.1.54
9. Azad M. B., Chen Y., Gibson S. B., Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxidants and Redox Signaling 2009 11 4 777 790 2-s2.0-60749108379 10.1089/ars.2008.2270
10. Pelicano H., Carney D., Huang P., ROS stress in cancer cells and therapeutic implications. Drug Resistance Updates 2004 7 2 97 110 2-s2.0-2942593991 10.1016/j.drup.2004.01.004 (Pubitemid 38736063)
11. Storz P., Reactive oxygen species in tumor progression. Frontiers in Bioscience 2005 10 2 1881 1896 2-s2.0-17244367828 (Pubitemid 40529044)
12. Oberley L. W., Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomedicine and Pharmacotherapy 2005 59 4 143 148 2-s2.0-18044364791 10.1016/j.biopha.2005.03.006 (Pubitemid 40603325)
13. Wiseman H., Halliwell B., Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochemical Journal 1996 313 1 17 29 2-s2.0-0030049032 (Pubitemid 26013419)
14. Leto T. L., Geiszt M., Role of Nox family NADPH oxidases in host defense. Antioxidants and Redox Signaling 2006 8 9-10 1549 1561 2-s2.0-33750926794 10.1089/ars.2006.8.1549 (Pubitemid 44726330)
15. Agnani D., Camacho-Vanegas O., Camacho C., Lele S., Odunsi K., Cohen S., Dottino P., Martignetti J. A., Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression. Journal of Ovarian Research 2011 4 1, article 18 2-s2.0-80054721603 10.1186/1757-2215-4-18
16. Paukert T., Sailer R., Strauss W. S. L., Schubert-Zsilavecz M., Zimmer A., Glutathione peroxidase isoenzymes in human tumor cell lines. Pharmazie 2011 66 11 894 898 2-s2.0-84055217337 10.1691/ph.2011.1540
17. Saga Y., Ohwada M., Suzuki M., Konno R., Kigawa J., Ueno S., Mano H., Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma. Oncology Reports 2008 20 6 1299 1303 2-s2.0-59249106025 10.3892/or-00000144
18. Brigelius-Flohé R., Kipp A., Glutathione peroxidases in different stages of carcinogenesis. Biochimica et Biophysica Acta 2009 1790 11 1555 1568 2-s2.0-72649092649 10.1016/j.bbagen.2009.03.006
19. Riveros-Rosas H., Julian-Sanchez A., Pina E., Enzymology of ethanol and acetaldehyde metabolism in mammals. Archives of Medical Research 1997 28 4 453 471 2-s2.0-0031440184 (Pubitemid 28014256)
20. Marchitti S. A., Chen Y., Thompson D. C., Vasiliou V., Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes. Eye and Contact Lens 2011 37 4 206 213 2-s2.0-79960002377 10.1097/ICL.0b013e3182212642
21. Marcato P., Dean C. A., Giacomantonio C. A., Lee P. W. K., Aldehyde dehydrogenase its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 2011 10 9 1378 1384 2-s2.0-79955593909 10.4161/cc.10.9.15486
22. Benson D. M. Jr., Panzner K., Hamadani M., Hofmeister C. C., Bakan C. E., Smith M. K., Elder P., Krugh D., O'Donnell L., Devine S. M., Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma. Leukemia and Lymphoma 2010 51 2 243 251 2-s2.0-76349087847 10.3109/10428190903480728
23. Sládek N. E., Kollander R., Sreerama L., Kiang D. T., Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Cancer Chemotherapy and Pharmacology 2002 49 4 309 321 2-s2.0-0036202207 10.1007/s00280-001-0412-4 (Pubitemid 34253270)
24. Douville J., Beaulieu R., Balicki D., ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells and Development 2009 18 1 17 26 2-s2.0-60149101077 10.1089/scd.2008.0055
25. Ma I., Allan A. L., The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Reviews and Reports 2011 7 2 292 306 2-s2.0-79955025420 10.1007/s12015-010-9208-4
26. Li T., Su Y., Mei Y., Leng Q., Leng B., Liu Z., Stass S. A., Jiang F., ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients outcome. Laboratory Investigation 2010 90 2 234 244 2-s2.0-75949101677 10.1038/labinvest.2009.127
27. Raz G., Allen K. E., Kingsley C., Cherni I., Arora S., Watanabe A., Lorenzo C. D., Edwards V D. K., Sridhar S., Hostetter G., Weiss G. J., Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer. Lung Cancer 2012 76 2 191 196 2-s2.0-84859434807 10.1016/j.lungcan.2011.10.015
28. Marcato P., Dean C. A., Da P., Araslanova R., Gillis M., Joshi M., Helyer L., Pan L., Leidal A., Gujar S., Giacomantonio C. A., Lee P. W. K., Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 2011 29 1 32 45 2-s2.0-79951818699 10.1002/stem.563
29. Liu D., Yang Z., Jiang S., Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Cancer Biomarkers 2010 8 3 113 121 2-s2.0-80055090764 10.3233/DMA-2011-0812
30. Zhang Y., Zhang X., Rabbani Z. N., Jackson I. L., Vujaskovic Z., Oxidative stress mediates radiation lung injury by inducing apoptosis. International Journal of Radiation Oncology, Biology, Physics 2012 83 740 748 2-s2.0-84855904385 10.1016/j.ijrobp.2011.08.005
31. Nishihara K., Nagai E., Izumi Y., Yamaguchi K., Tsuneyoshi M., Adenosquamous carcinoma of the gallbladder: a clinicopathological, immunohistochemical and flow-cytometric study of twenty cases. Japanese Journal of Cancer Research 1994 85 4 389 399 2-s2.0-0028260225 (Pubitemid 24129620)
32. Kondo M., Dono K., Sakon M., Shimizu J., Nagano H., Nakamori S., Umeshita K., Wakasa K., Monden M., Adenosquamous carcinoma of the gallbladder. Hepato-Gastroenterology 2002 49 47 1230 1234 2-s2.0-0036375134
33. Shibata T., Kokubu A., Gotoh M., Ojima H., Ohta T., Yamamoto M., Hirohashi S., Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder Cancer. Gastroenterology 2008 135 4 1358 1368 2-s2.0-53049105119 10.1053/j.gastro.2008.06.082
34. Muzio G., Maggiora M., Paiuzzi E., Oraldi M., Canuto R. A., Aldehyde dehydrogenases and cell proliferation. Free Radical Biology and Medicine 2012 52 4 735 746 2-s2.0-84856223248 10.1016/j.freeradbiomed.2011.11.033
35. Yoshida A., Dave V., Han H., Scanlon K. J., Enhanced transcription of the cytosolic ALDH gene in cyclophosphamide resistant human carcinoma cells. Advances in Experimental Medicine and Biology 1993 328 63 72 2-s2.0-0027499991 (Pubitemid 23119221)